Financials

News Ideas Discussions Technicals Forecast Seasonals

4VRTX fundamentals

Overview Statements Statistics Dividends Earnings Revenue

The current financial position of VERTEX PHARMACEUTICALS

Total assets of 4VRTX for Q1 25 is 21.15 B EUR, 5.18% less than the previous Q4 24. And total liabilities decreased by 8.56% in Q1 25 to 5.9 B EUR.

Q2 '17

Q3 '17

Q4 '17

Q1 '18

Q2 '18

Q3 '18

Q4 '18

Q1 '19

Q2 '19

Q3 '19

Q4 '19

Q1 '20

Q2 '20

Q3 '20

Q4 '20

Q1 '21

Q2 '21

Q3 '21

Q4 '21

Q1 '22

Q2 '22

Q3 '22

Q4 '22

Q1 '23

Q2 '23

Q3 '23

Q4 '23

Q1 '24

Q2 '24

Q3 '24

Q4 '24

Q1 '25

Total assets

Total liabilities

Income statement Balance sheet Cash flow

Currency: EUR